For the millions of people living with diabetes or obesity, drugs like Ozempic and Wegovy can significantly improve their ...

Mount Sinai Health System is teaming up with a major health startup aimed at behavioral approaches to weight loss. The ...

Members of the Senate criticized the "outrageously high" prices for the popular weight loss drugs Ozempic and Wegovy. Sen. Bernie Sanders told Novo Nordisk, the manufacturer of the drugs, to stop ...

虽然联合治疗数据有可能在今年晚些时候推高诺和诺德的股价，但预期已经很高了。该股的远期市盈率为36倍。对于一家过去三年收益增长81%的公司来说，这是一个合理的价格，但前提是我们可以预期收益继续飙升。

The boss of the Danish pharmaceutical giant behind the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy promised Tuesday to examine lowering their prices in the United States, after ...

Novo Nordisk has been criticised by US politicians for the high pricing of its popular weight-loss and diabetes drugs. But ...

The head of Ozempic manufacturer Novo Nordisk on Tuesday defended the high price of the company’s highly sought-after obesity and Type 2 diabetes drugs, blaming pharma middlemen ...

Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO ...

Harvard Medical School professor Joel F. Habener won the 2024 Lasker-DeBakey Clinical Medical Research Award for his work on ...

The CEO of Novo Nordisk took questions for more than two hours during a Senate Health Committee hearing focused on addressing ...

GLP-1 weight-loss drugs alleviate obesity as well as provide other health benefits. Yet they are also the focus of ...

Novo Nordisk and Eli Lilly are expected to rule the obesity market for a few more years without much challenge. To ensure they stay there as competition enters, the companies are spending billions in ...